May 3, 2024

Ruda Mohaweche, MD


May 3, 2024

Timothy R. Heath, MD


May 3, 2024

Puja B. Gandhi, MD, MPH

Dr. Puja Gandhi earned her BS in Human Biology and Anthropology from Emory University in Atlanta, Georgia. She earned her MPH from UTHealth Houston School of Public Health as well as her MD from McGovern Medical School at UTHealth Houston…


April 18, 2024

In Memoriam: Dr. Barbara Murray

Barbara E. Murray, MD, J. Ralph Meadows Professor of Medicine in the Division of Infectious Diseases, Department of Internal Medicine, died April 11, 2024. She was 76. A member of the Medical School’s ID faculty since 1980, she was a…


March 13, 2024

UTHealth Houston research: semaglutide reduces severity of fatty liver disease in people with HIV

Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston. The use of semaglutide 1mg weekly was safe and effective in improving metabolic…


March 13, 2024

Sanjay Awasthi, MD

Dr. Sanjay Awasthi is a distinguished oncologist and researcher with extensive experience in hematology, oncology, and cancer research. He currently serves as a Professor in the Department of Internal Medicine, Division of Hematology & Oncology at UTHealth Houston. Dr. Awasthi…


February 23, 2024

Jennifer Sunny, DO


February 15, 2024

UTHealth Houston report in NEJM: Deadly fungal infection acquired during surgery in Mexico led to death and brainstem, blood supply injuries

A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston. A report, led by…


February 15, 2024

UTHealth Houston opens recruitment in RISE-UP clinical drug trial for people with sickle cell anemia

A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth…


Pages